Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer

Breast

Volumn 22, Issue 5, 2013, Pages 634-638

  Sharp, Lena ^a,b   Johansson, Hemming ^a,b   Hatschek, Thomas ^a,b   Bergenmar, Mia ^a,b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Breast neoplasms; Dermatitis; Outcome assessment; Radiotherapy; Risk factors; Smoking

Indexed keywords

ACUTE RADIATION SKIN REACTION; ADULT; AGED; ARTICLE; BODY MASS; BREAST CANCER; CANCER RADIOTHERAPY; EORTC QLQ C30; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MOS SLEEP QUESTIONNAIRE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RATING SCALE; RTOG EORTC SCALE; SKIN MANIFESTATION; SLEEP DISORDER; SMOKING; VISUAL ANALOG SCALE;

BREAST NEOPLASMS; DERMATITIS; OUTCOME ASSESSMENT; RADIOTHERAPY; RISK FACTORS; SMOKING;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BODY MASS INDEX; BREAST NEOPLASMS; DYSSOMNIAS; FEMALE; HUMANS; MIDDLE AGED; QUALITY OF LIFE; RADIODERMATITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SKIN CREAM; SMOKING;

EID: 84884159180     PISSN: 09609776     EISSN: 15323080     Source Type: Journal    
DOI: 10.1016/j.breast.2013.07.047     Document Type: Article

References (38)

1. Wells M., Macmillan M., Raab G., MacBride S., Bell N., MacKinnon K., et al. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol 2004, 73:153-162.
2. Kirova Y.M., Fromantin I., De Rycke Y., Fourquet A., Morvan E., Padiglione S., et al. Can we decrease the skin reaction in breast cancer patients using hyaluronic acid during radiation therapy? Results of phase III randomised trial. Radiother Oncol 2011, 100:205-209.
3. Miller R.C., Schwartz D.J., Sloan J.A., Griffin P.C., Deming R.L., Anders J.C., et al. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys 2011, 79:1460-1466.
4. Sharp L., Johansson H., Landin Y., Moegelin I.M., Bergenmar M. Frequency and severity of skin reactions in patients with breast cancer undergoing adjuvant radiotherapy, the usefulness of two assessment instruments - a pilot study. Eur J Cancer 2011, 47:2665-2672.
5. Sharp L., Finnilä K., Johansson H., Abrahamsson M., Hatschek T., Bergenmar M. No differences between calendula cream and aqueous cream in the prevention of acute radiation skin reactions - results from a randomised blinded trial. Eur J Oncol Nurs 2012 Dec 12, [Epub ahead of print]. 10.1016/j.ejon.2012.11.003.
6. Livi L., Saieva C., Borghesi S., Paoletti L., Meattini I., Rampini A., et al. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. Int J Radiat Oncol Biol Phys 2008, 71:705-709.
7. Fenig E., Brenner B., Katz A., Sulkes J., Lapidot M., Schachter J., et al. Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial. Oncol Rep 2001, 8:305-309.
8. Heggie S., Bryant G.P., Tripcony L., Keller J., Rose P., Glendenning M., et al. Aphase III study on the efficacy of topical aloe vera gel on irradiated breast tissue. Cancer Nurs 2002, 25:442-451.
9. Gosselin T.K., Schneider S.M., Plambeck M.A., Rowe K. Aprospective randomized, placebo-controlled skin care study in women diagnosed with breast cancer undergoing radiation therapy. Oncol Nurs Forum 2010, 37:619-626.
10. Boström A., Lindman H., Swartling C., Berne B., Bergh J. Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis:results from a double-blind, randomized study. Radiother Oncol 2001, 59:257-265.
11. Schmuth M., Wimmer M.A., Hofer S., Sztankay A., Weinlich G., Linder D.M., et al. Topical corticosteroid therapy for acute radiation dermatitis: a prospective, randomized, double-blind study. Br J Dermatol 2002, 146:983-991.
12. Pommier P., Gomez F., Sunyach M.P., D'Hombres A., Carrie C., Montbarbon X. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer. JClin Oncol 2004, 22:1447-1453.
13. Primavera G., Carrera M., Berardesca E., Pinnaró P., Messina M., Arcangeli G. Adouble-blind, vehicle-controlled clinical study to evaluate the efficacy of MAS065D (XClair), a hyaluronic acid-based formulation, in the management of radiation-induced dermatitis. Cutan Ocul Toxicol 2006, 25:165-171.
14. Pinnix C., Perkins G.H., Strom E.A., Tereffe W., Woodward W., Oh J.L., et al. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial. Int J Radiat Oncol Biol Phys 2012, 83:1089-1094.
15. Corvò R., Giudici S., Maggio F., Bevegni M., Sampietro C., Lucido M.R., et al. Weekly concomitant boost in adjuvant radiotherapy for patients with early breast cancer: preliminary results on feasibility. Tumori 2008, 94:706-711.
16. Osako T., Oguchi M., Kumada M., Nemoto K., Iwase T., Yamashita T. Acute radiation dermatitis and pneumonitis in Japanese breast cancer patients with whole breast hypofractionated radiotherapy compared to conventional radiotherapy. Jpn J Clin Oncol 2008, 38:334-338.
17. Back M., Guerrieri M., Wratten C., Steigler A. Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer. Clin Oncol (R Coll Radiol 2004, 16:12-16.
18. Iwakawa M., Noda S., Yamada S., Yamamoto N., Miyazawa Y., Yamazaki H., et al. Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer 2006, 13:300-307.
19. Pignol J.P., Olivotto I., Rakovitch E., Gardner S., Sixel K., Beckham W., et al. Amulticenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. JClin Oncol 2008, 26:2085-2092.
20. Fiets W.E., van Helvoirt R.P., Nortier J.W.R., van der Tweel I., Struikmans H. Acute toxicity of concurrent adjuvant radiotherapy and chemotherapy (CMF or AC) in breast cancer patients: a prospective, comparative, non-randomised study. Eur J Cancer 2003, 39:1081-1088.
21. Halyard M.Y., Pisansky T.M., Dueck A.C., Suman V., Pierce L., Solin L., et al. Radiotherapy and adjuvant trastuzumab in operable breast cancer: tolerability and adverse event data from the NCCTG Phase III Trial N9831. JClin Oncol 2009, 27:2638-2644.
22. Twardella D., Popanda O., Helmbold I., Ebbeler R., Benner A., von Fournier D., et al. Personal characteristics, therapy modalities and individual DNA repaircapacity as predictive factors of acute skin toxicity in an unselected cohort of breast cancer patients receiving radiotherapy. Radiother Oncol 2003, 69:145-153.
23. Turesson I., Nyman J., Holmberg E., Odén A. Prognostic factors for acute and late skin reactions in radiotherapy patients. Int J Radiat Oncol Biol Phys 1996, 36:1065-1075.
24. Pires A.M., Segreto R.A., Segreto H.R. RTOG criteria to evaluate acute skin reaction and its risk factors in patients with breast cancer submitted to radiotherapy. Rev Lat Am Enfermagem 2008, 16:844-849.
25. Morganti A.G., Digesù C., Panunzi S., De Gaetano A., Macchia G., Deodato F., et al. Radioprotective effect of moderate wine consumption in patients with breast carcinoma. Int J Radiat Oncol Biol Phys 2009, 74:1501-1505.
26. Sharp L., Johansson H., Fagerström K., Rutqvist L.E. Smoking cessation among patients with head and neck cancer: cancer as a 'teachable moment'. Eur J Cancer Care (Engl) 2008, 17:114-119.
27. Cox J.D., Stetz J., Pajak T.F. Toxicity criteria of the radiation therapy oncology group (RTOG) and the European Organization for research and treatment of cancer (EORTC). Int J Radiat Oncol Biol Phys 1995, 3:1341-1346.
28. Aaronson N.K., Ahmedzai S., Bergman B., Bullinger M., Cull A., Duez N.J., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNatl Cancer Inst 1993, 85:365-376.
29. Cull A.M. Cancer-specific quality of life questionnaires: the state of the art in Europe. Eur J Cancer 1997, 33(Suppl 6):S3-S7.
30. Hays R.D., Martin S.A., Sesti A.M., Spritzer K.L. Psychometric properties of the medical outcomes study sleep measure. Sleep Med 2005, 6:41-44.
31. Bijur P.E., Silver W., Gallagher E.J. Reliability of the visual analog scale for measurement of acute pain. Acad Emerg Med 2001, 8:1153-1157.
32. Osoba D., Rodrigues G., Myles J., Zee B., Pater J. Interpreting the significance of changes in health-related quality-of-life scores. JClin Oncol 1998, 16:139-144.
33. Sauerbrei W., Schumacher A. Abootstrap resampling procedure for modelbuilding: application to the Cox regression model. Stat Med 1992, 11:2093-2109.
34. Hald J., Overgaard J., Grau C. Evaluation of objective measures of smoking status - a prospective clinical study in a group of head and neck cancer patients treated with radiotherapy. Acta Oncol 2003, 43:154-159.
35. Prochazka M., Hall P., Gagliardi G., Granath F., Nilsson B.N., Shields P.G., et al. Ionizing radiation and tobacco use increases the risk of a subsequent lung carcinoma in women with breast cancer: case-only design. Clin Oncol 2005, 23:7467-7474.
36. Jagsi R., Griffith K.A., Koelling T., Roberts R., Pierce L.J. Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer 2007, 109:650-657.
37. Hanna Y.M., Baglan K.L., Stromberg J.S.S., Vicini F.A., Decker D.A., et al. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J 2002, 8:149-153.
38. Lopez E., Nunez M.I., Guerrero M.R., del Moral R., de Dios Luna J., del Mar Rodríguez M., et al. Breast cancer acute radiotherapy morbidity evaluated by different scoring systems. Breast Cancer Res Treat 2002, 73:127-134.